617 filings
8-K
ENVB
Enveric Biosciences Inc
23 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00am
8-K
ENVB
Enveric Biosciences Inc
17 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:25pm
10-Q
2024 Q1
ENVB
Enveric Biosciences Inc
Quarterly report
14 May 24
9:20pm
8-K
ENVB
Enveric Biosciences Inc
14 May 24
Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results
9:15pm
424B5
ENVB
Enveric Biosciences Inc
3 May 24
Prospectus supplement for primary offering
5:05pm
8-K
pd23bi6l4 cvwbx6xa
3 May 24
Entry into a Material Definitive Agreement
5:04pm
ARS
2m03h5beimtrq 0xw0
16 Apr 24
Annual report to shareholders
8:35am
8-K
zq5npl
28 Mar 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:55pm
8-K
e15zo
26 Mar 24
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
8:00am
8-K
zhwpkwr id3sa4crhp
19 Mar 24
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive
7:00am
424B5
qavpdgrhfkutkl4g8q
11 Mar 24
Prospectus supplement for primary offering
12:35pm
8-K
hmpqpwmlosiv
11 Mar 24
Entry into a Material Definitive Agreement
8:00am
8-K
ms4hxs4mvgan9mu3
29 Feb 24
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
7:00am
8-K
qeek d5662oqthq4f
21 Feb 24
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders
8:05am
8-K
u31ruul0fe2v6cwl3
9 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:05am
424B3
uxmso0
24 Jan 24
Prospectus supplement
8:05am
EFFECT
k165nqbwh
23 Jan 24
Notice of effectiveness
12:15am
CORRESP
el13 i1h0ah6g7i
19 Jan 24
Correspondence with SEC
12:00am